1[1]F Capsoni,F Minonzio,A Mongari, et al. Evaulation of the kinetics of the imunomodulation activity of pidotimod on human[J].Neutrophils pharmacol,Res,1992,26(Suppl 2):172.
2[2]Barchielli,M,Coppi G.et al.Experimental studies on PGT/1A,a new immunostimulating drug[J].Eur J Pharmacol, 1990,183:909.
3[3]P Careddu,V Mei,Venturoli,et al. Pidotimod in the treatment of recurrent respiratory infections in the paediatric patients[J].ArzneimforForsch/Drug Res, 1994,44:1 485.
4[4]G Motta, E De Campora C,De Vita,et al. Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood[J].Arzneim-Forsch/Drug Res,1994,44:1 521.
5[5]E Clemente,R Solli,V Mei, et al. Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children[J].Arzneim-Forsch/Drug Res, 1994,44:1 490.
6[6]E Pozzi, A Dolcetti, O Orlandi, et al. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchiyis[J].Arzneim-Forsch/Drug Res, 1994,44:1 495.
7[7]G P benetti,M IIIeni,A Passera,et al. Exvivo evaluation of pidotimod activity in patient with chronic obstructive pulmonary disease[J].Arzneim-Forsch/Drug Res, 1994,44:1 503.
